AGAPE ATP CORPORATION Accounts Payable and Other Accrued Liabilities
AGAPE ATP CORPORATION (ATPC) had Accounts Payable and Other Accrued Liabilities of $329.70 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:AccountsPayableAndOtherAccruedLiabilities · last filed 2026-08-14
- 2026-06-30: Accounts Payable and Other Accrued Liabilities $329.70K.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities $165.53K.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities $183.16K; Accounts Payable and Other Accrued Liabilities as first filed $191.70K.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities $149.79K.
| Period end | Accounts Payable and Other Accrued Liabilities | Accounts Payable and Other Accrued Liabilities as first filed |
|---|---|---|
| 2026-06-30 | $329.70K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $165.53K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $183.16K 10-Q · filed 2026-08-14 | $191.70K 10-K · filed 2026-04-13 |
| 2025-09-30 | $149.79K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $138.13K 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $89.63K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $62.82K 10-K · filed 2026-04-13 | |
| 2024-09-30 | $67.29K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $37.12K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $33.94K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $43.16K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $10.26K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $8.47K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $16.80K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $37.85K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $32.20K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $77.39K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $155.47K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $64.34K 10-K · filed 2023-03-31 | $143.40K 10-K · filed 2022-03-28 |
| 2021-09-30 | $53.87K 10-Q/A · filed 2022-07-05 | |
| 2021-06-30 | $63.69K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $75.70K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $63.92K 10-Q/A · filed 2022-07-05 | |
| 2020-09-30 | $78.79K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $63.25K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $28.98K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $18.65K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $36.41K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $12.32K 10-K · filed 2020-03-27 | $12.36K 10-K · filed 2019-09-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |